A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.
about
Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth.EPIG-Seq: extracting patterns and identifying co-expressed genes from RNA-Seq data.Do serum biomarkers really measure breast cancer?Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progressionDiscovery of pathway biomarkers from coupled proteomics and systems biology methodsExpression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerElevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer.A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growth.Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysisThe Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells.Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.Parity and expression of epithelial histopathologic markers in breast tissue.Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.Nuclear protein isoforms: implications for cancer diagnosis and therapy.Long non-coding RNA AK093407 promotes proliferation and inhibits apoptosis of human osteosarcoma cells via STAT3 activation.Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liverCucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.Comparative analysis of pre-replication complex proteins in transformed and normal cells.Antiproliferative effects of apple peel extract against cancer cells.Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation.Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA.Interaction of estrogen receptor alpha with proliferating cell nuclear antigen.Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.Deviating the level of proliferating cell nuclear antigen in Trypanosoma brucei elicits distinct mechanisms for inhibiting proliferation and cell cycle progression.Protein biomarker of cell proliferation determines survival to discharge in cases of equine large colon volvulus.Identification of differentially expressed genes and biological pathways in bladder cancer.Study of Proliferating cell nuclear antigen expression and Angiogenesis in Urothelial neoplasms: Correlation with tumor grade and stage.Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
P2860
Q30364263-FD5FA074-0AEE-4316-ACCF-153478A24286Q30821888-2AB803D8-DBB9-4682-B7E3-6E943F3346A9Q31049735-1BF99A56-BE38-4C2A-844F-A9366B9F1D68Q31061755-54C25992-B86A-4525-A829-8F1721751B62Q33454967-0CB89146-6453-414A-BA1A-4AE30FB9D12EQ33531529-B92B3157-6191-4E57-A72A-3A59B1CCF777Q33737009-9179BB29-69FA-43F6-BC31-9BB93A62305DQ33763213-11DC18AC-2F44-4285-ABDC-F75E9456C379Q34578129-F11EE357-5637-46C4-ABC9-22AFFBE3A115Q34624841-05767211-FEAB-4C85-AD94-C158EDB7AC85Q34946808-3563E9A2-F663-4993-A665-7B248FF2618FQ35146771-E0910EDA-C2D7-4A75-9B38-9850482A6D25Q36264339-7B399B1C-A757-45B2-9BA3-EE9A40BE2D53Q36437713-C0F18774-FB7E-4DBF-A6EB-2D8B24E5A186Q36737982-F93B0AAB-FCB7-4E46-A1C8-CC30893043EDQ36844270-6249D37A-1AE2-4A9B-A386-AE7460CA0847Q37071560-94757952-5876-441C-90E2-D226443FAFEBQ37183528-0C70AEF1-06F3-480C-86CC-4A89494E7F9EQ37722121-D274C5B1-48D3-441E-BFF0-A5A5BE820E0EQ37843948-3192339A-ED26-48EC-9414-F043A035BEEDQ38704957-768079C1-7EED-438C-945D-E4DB3EEA0D39Q38881220-EEFF169B-E370-4DD0-9FB4-18EED96EAFB4Q39142203-DD28054C-9952-4D13-BEBF-CCB762247AAFQ39306606-EEEC5CBD-7620-46FD-8DAD-05EB7C831996Q39434288-F149CD05-AD53-463C-8806-B3D64E10A399Q39708994-9E392E2D-BF5C-4635-AB99-F54386876155Q39976008-F01A0544-CC51-4136-8040-4918F335C28BQ40075270-BCEA2C41-EA13-41C9-A373-93FC0FCD614FQ40106128-500DC439-EAC7-4AA7-89E6-BFDC414AC632Q41921772-A6AAEE32-B62D-47AC-BF83-32341B2359BCQ43207731-CF020688-F0FF-47B6-B40A-FB4905CC2760Q44876211-1A31BFFD-1F3B-4418-BC77-9D41A5E10934Q52658556-C16A22EA-DE21-469F-B962-EF511348B072Q55049259-6CCE9185-666E-4777-A59D-0E0B95B8E984Q57489971-3425E64A-2F69-4DF5-A037-3038F57714EC
P2860
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@ast
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@en
type
label
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@ast
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@en
prefLabel
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@ast
A cancer-associated PCNA expre ...... ions as a potential biomarker.
@en
P2093
P2860
P356
P1476
A cancer-associated PCNA expre ...... tions as a potential biomarker
@en
P2093
Beamon Agarwal
Derek Hoelz
Lacey E Dobrolecki
Lauren Schnaper
Linda H Malkas
Milos V Novotny
Patrick Loehrer
Randy J Arnold
Robert J Goulet
Robert J Hickey
P2860
P304
19472-19477
P356
10.1073/PNAS.0604614103
P407
P577
2006-12-11T00:00:00Z